1. Table of Contents
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Bacterial Vaginosis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Bacterial Vaginosis Clinical Trials by Region
2.2.2 Average Enrollment of Bacterial Vaginosis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Bacterial Vaginosis Treatment, 2019

3. Region wise Bacterial Vaginosis Clinical Trials
3.1 Asia Pacific Bacterial Vaginosis Clinical Trials by Country
3.2 Europe Bacterial Vaginosis Clinical Trials by Country
3.3 North America Bacterial Vaginosis Clinical Trials by Country
3.4 Middle East and Africa Bacterial Vaginosis Clinical Trials by Country
3.5 South and Central America Bacterial Vaginosis Clinical Trials by Country

4. Bacterial Vaginosis Clinical Trial Trends
4.1 Start Year wise Bacterial Vaginosis Clinical Trials
4.2 Phase wise Bacterial Vaginosis Clinical Trials
4.3 Trial Status wise Bacterial Vaginosis Clinical Trials
4.4 Trial Type wise Bacterial Vaginosis Clinical Trials

5. Bacterial Vaginosis Average Enrollment Trends
5.1 Average Enrollment in Bacterial Vaginosis Trials by Year
5.2 Average Enrollment in Bacterial Vaginosis Trials by Phase
5.3 Average Enrollment in Bacterial Vaginosis Trials by Status
5.4 Average Enrollment in Bacterial Vaginosis Trials by Type of Trial

6. Companies Participating in Bacterial Vaginosis Clinical Trials
6.1 Bacterial Vaginosis Trials by Sponsor Type
6.2 Bacterial Vaginosis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Bacterial Vaginosis Trials- Phase 1
7.2 Bacterial Vaginosis Trials- Phase 2
7.3 Bacterial Vaginosis Trials- Phase 3
7.4 Bacterial Vaginosis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Bacterial Vaginosis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Bacterial Vaginosis Clinical Trials and Enrolment
Figure 5: Europe – Country wise Bacterial Vaginosis Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Bacterial Vaginosis Clinical Trials and Enrolment
Figure 7: North America – Country wise Bacterial Vaginosis Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Bacterial Vaginosis Clinical Trials and Enrolment
Figure 9: Bacterial Vaginosis Clinical Trials by Phase
Figure 10: Bacterial Vaginosis Clinical Trials by Trial Status
Figure 11: Bacterial Vaginosis Clinical Trials by Type
Figure 12: Bacterial Vaginosis Clinical Trials by Sponsor Type
Figure 13: Bacterial Vaginosis Clinical Trials by Leading Sponsors
Figure 14: Bacterial Vaginosis Average Enrollment by Phase
Figure 15: Bacterial Vaginosis Average Enrollment by Trial Status
Figure 16: Bacterial Vaginosis Average Enrollment by Type
Figure 17: Bacterial Vaginosis- Average Enrolment by Type of Sponsors
Figure 18: Bacterial Vaginosis- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List of Tables
Table 1: Bacterial Vaginosis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Bacterial Vaginosis Clinical Trials and Enrolment
Table 5: Europe – Country wise Bacterial Vaginosis Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Bacterial Vaginosis Clinical Trials and Enrolment
Table 7: North America – Country wise Bacterial Vaginosis Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Bacterial Vaginosis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Bacterial Vaginosis Average Enrollment by Phase
Table 15: Bacterial Vaginosis Average Enrollment by Trial Status
Table 16: Bacterial Vaginosis Average Enrollment by Type
Table 17: Bacterial Vaginosis- Average Enrolment by Type of Sponsors
Table 18: Bacterial Vaginosis- Enrolment by Leading Sponsors

Companies mentioned
AlfaSigma SpA, Allergan Plc, AmVac AG, Bausch Health Companies Inc, Bifodan A/S, Ferring Holding SA, Hammock Pharmaceuticals Inc, Lupin Ltd, Osel Inc, Starpharma Holdings Ltd